» Articles » PMID: 27974799

Early Dissemination Seeds Metastasis in Breast Cancer

Abstract

Accumulating data suggest that metastatic dissemination often occurs early during tumour formation, but the mechanisms of early metastatic spread have not yet been addressed. Here, by studying metastasis in a HER2-driven mouse breast cancer model, we show that progesterone-induced signalling triggers migration of cancer cells from early lesions shortly after HER2 activation, but promotes proliferation in advanced primary tumour cells. The switch from migration to proliferation was regulated by increased HER2 expression and tumour-cell density involving microRNA-mediated progesterone receptor downregulation, and was reversible. Cells from early, low-density lesions displayed more stemness features, migrated more and founded more metastases than cells from dense, advanced tumours. Notably, we found that at least 80% of metastases were derived from early disseminated cancer cells. Karyotypic and phenotypic analysis of human disseminated cancer cells and primary tumours corroborated the relevance of these findings for human metastatic dissemination.

Citing Articles

Recurrent alterations are associated with esophageal adenocarcinoma brain metastases.

Lawson N, Ye L, Cho C, Zhao B, Mitchell T, Martin-Barrio I medRxiv. 2025; .

PMID: 40061311 PMC: 11888521. DOI: 10.1101/2025.02.19.25322558.


Brd7 loss reawakens dormant metastasis initiating cells in lung by forging an immunosuppressive niche.

Mondal J, Zhang J, Qing F, Li S, Kumar D, Huse J Nat Commun. 2025; 16(1):1378.

PMID: 39910049 PMC: 11799300. DOI: 10.1038/s41467-025-56347-2.


Ezrin Polarization as a Diagnostic Marker for Circulating Tumor Cells in Hepatocellular Carcinoma.

Budeyri I, Guckelberger O, Oppermann E, Roy D, Sliwinski S, Becker F Cells. 2025; 14(1.

PMID: 39791707 PMC: 11720075. DOI: 10.3390/cells14010006.


De novo lipogenesis protects dormant breast cancer cells from ferroptosis and promotes metastasis.

Puente-Cobacho B, Esteo C, Altea-Manzano P, Garcia-Perez J, Quiles J, Sanchez-Rovira P Redox Biol. 2025; 80:103480.

PMID: 39787900 PMC: 11764609. DOI: 10.1016/j.redox.2024.103480.


Her2 promotes early dissemination of breast cancer by inhibiting the p38 pathway through the downregulation of MAP3K4.

Wang G, Wen P, Xue T, Huang Y, Shao Q, Zhang N Cell Commun Signal. 2024; 22(1):611.

PMID: 39702199 PMC: 11660853. DOI: 10.1186/s12964-024-02000-2.


References
1.
Asselin-Labat M, Shackleton M, Stingl J, Vaillant F, Forrest N, Eaves C . Steroid hormone receptor status of mouse mammary stem cells. J Natl Cancer Inst. 2006; 98(14):1011-4. DOI: 10.1093/jnci/djj267. View

2.
Ignatiadis M, Rothe F, Chaboteaux C, Durbecq V, Rouas G, Criscitiello C . HER2-positive circulating tumor cells in breast cancer. PLoS One. 2011; 6(1):e15624. PMC: 3018524. DOI: 10.1371/journal.pone.0015624. View

3.
Hutchinson J, Jin J, Cardiff R, Woodgett J, Muller W . Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion. Cancer Res. 2004; 64(9):3171-8. DOI: 10.1158/0008-5472.can-03-3465. View

4.
Dueck A, Eichner A, Sixt M, Meister G . A miR-155-dependent microRNA hierarchy in dendritic cell maturation and macrophage activation. FEBS Lett. 2014; 588(4):632-40. DOI: 10.1016/j.febslet.2014.01.009. View

5.
Klein C . Framework models of tumor dormancy from patient-derived observations. Curr Opin Genet Dev. 2010; 21(1):42-9. DOI: 10.1016/j.gde.2010.10.011. View